Neurocognitive impact of antiretroviral treatment: Thinking long-term

Current HIV/AIDS Reports

Volumn 8, Issue 4, 2011, Pages 249-256

  McPhail, Megan E ^a   Robertson, Kevin R ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Aging; AIDS; Cardiovascular; cART; CNS penetration; Comorbidity; HAND; HIV; Neurocognitive; Neurotoxicity

Indexed keywords

ANTIRETROVIRUS AGENT;

AGING; ARTICLE; CENTRAL NERVOUS SYSTEM; COMORBIDITY; FOLLOW UP; HEPATITIS C VIRUS; HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NEUROTOXICITY; THINKING;

AIDS DEMENTIA COMPLEX; ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; HUMANS; PREVALENCE;

EID: 81355138648     PISSN: 15483568     EISSN: 15483576     Source Type: Journal    
DOI: 10.1007/s11904-011-0091-7     Document Type: Article

References (75)

1. •• Simioni S, Cavassini M, Annoni JM, et al. Cognitive dysfunction in HIV patients despite long-standing suppression of viremia. AIDS 2009. This study indicates that the prevalence of cognitive complaints and HAND remains elevated in HIV-infected individuals who have been optimally treated and who have undetectable HIV-1 RNA concentrations.
2. LA Cysique P Maruff BJ Brew 2004 Prevalence and pattern of neuropsychological impairment in human immunodeficiency virus-infected/acquired immunodeficiency syndrome (HIV/AIDS) patients across pre- and post-highly active antiretroviral therapy eras: a combined study of two cohorts J Neurovirol 10 350 7 15765806 10.1080/13550280490521078 (Pubitemid 40109622)
3. J Schouten P Cinque M Gisslen, et al. 2011 HIV-1 infection and cognitive impairment in the cART era: a review AIDS 25 000 16 10.1097/QAD.0b013e3283437f9a
4. A Antinori G Arendt JT Becker, et al. 2007 Updated research nosology for HIV-associated neurocognitive disorders Neurology 69 18 1789 99 17914061 10.1212/01.WNL.0000287431.88658.8b 1:STN:280:DC%2BD2snktFyqsQ%3D%3D (Pubitemid 350059308)
5. J Foley M Ettenhofer M Wright C Hinkin 2008 Emerging issues in the neuropsychology of HIV infection Curr HIV/AIDS Rep 5 204 11 18838060 10.1007/s11904-008-0029-x
6. BC Dennis SA Houff DY Han FA Schmitt 2011 Development of neurocognitive disorders in HIV/AIDS Neurobehav HIV Med 3 9 18
7. V Tozzi P Balestra S Galgani, et al. 2003 Neurocognitive performance and quality of life in patients with HIV infection AIDS Res Hum Retroviruses 19 643 52 13678465 10.1089/088922203322280856 (Pubitemid 37047088)
8. SM Albert K Marder G Doonief, et al. 1995 Neurospychological impairment in early HIV infection. A risk factor for work disability Arch Neurol 52 525 30 7733849 1:STN:280:DyaK2M3ltFGktw%3D%3D
9. RK Heaton RA Velin JA McCutchan, et al. 1994 Neuropsychological impairment in human immunodeficiency virus-infection: implications for employment Psychosom Med 56 8 17 8197319 1:STN:280:DyaK2c3lsFKhsA%3D%3D (Pubitemid 24054867)
10. CH Hinkin DJ Hardy KI Mason, et al. 2004 Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse AIDS 18 suppl 1 S19 25 15075494
11. SP Woods LM Moran CL Carey, et al. 2008 Prospective memory in HIV infection: is 'remembering to remember' a unique predictor of self-reported medication management? Arch Clin Neuropsychol 23 257 70 18243645 10.1016/j.acn.2007.12.006
12. K Robertson M Smurzynski T Parsons, et al. 2007 The prevalence and incidence of neurocognitive impairment in the HAART era AIDS 21 1915 21 17721099 10.1097/QAD.0b013e32828e4e27 (Pubitemid 47329768)
13. RK Heaton DB Clifford DR Franklin, et al. 2010 Neurology 75 2087 95 21135382 10.1212/WNL.0b013e318200d727 The CHARTER study presents baseline data on the frequency and associated features of HAND in 1555 HIV-infected subjects. Milder forms of neurocognitive impairment were found to be prevalent in this cohort, even among those receiving cART who had minimal comorbidities.
14. RK Heaton I Grant N Butters, et al. 1995 The HNRC 500: neuropsychology of HIV infection at different disease stages: HIV Neurobehavioral Research Center J Int Neuropsychol Soc 1 231 51 9375218 10.1017/S1355617700000230 1:STN:280:DyaK1c%2Fkt1Orug%3D%3D
15. DA White RK Heaton AU Monsch 1995 Neuropsychological studies of asymptomatic human immunodeficiency virustype-1 infected individuals: The HNRC Group: HIV Neurobehavioral Research Center J Int Neuropsychol Soc 1 304 15 9375225 10.1017/S1355617700000308 1:STN:280:DyaK1c%2Fkt1Oqtw%3D%3D
16. PR Harrington G Schnell SL Letendre, et al. 2009 Cross-sectional characterization of HIV-1 env compartmentalization in cerebrospinal fluid over the full disease course AIDS 23 8 907 15 19414991 10.1097/QAD.0b013e3283299129
17. G Schnell RW Price R Swanstrom S Spudich 2010 Compartmentalization and clonal amplification of HIV-1 variants in the cerebrospinal fluid during primary infection J Virol 84 5 2395 407 20015984 10.1128/JVI.01863-09 1:CAS:528:DC%2BC3cXisVCjtbw%3D
18. LA Cysique P Maruff BJ Brew 2006 Variable benefit in neuropsychological function in HIV-infected HAART-treated patients Neurology 66 9 1447 50 16682686 10.1212/01.wnl.0000210477.63851.d3
19. S Letendre J McCutchan M Childers, et al. 2004 Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders Ann Neurol 56 416 23 15349869 10.1002/ana.20198 (Pubitemid 39166561)
20. Letendre S. Revised CNS penetration-effectiveness ranks. In 17th Conference on Retroviruses and Opportunistic Infections. San Francisco, CA; 2010.
21. M Smurzynski K Wu S Letendre, et al. 2011 Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohort AIDS 25 357 65 21124201 10.1097/QAD.0b013e32834171f8
22. B Brew 2009 HIV, the brain, children, HAART and 'neuro-HAART': a complex mix AIDS 23 1909 10 19550290 10.1097/QAD.0b013e32832ec4c6
23. K Patel X Ming PL Williams, et al. 2009 Impact of HAART and CNS-penetrating antiretroviral regimens on HIV encephalopathy among perinatally infected children and adolescents AIDS 23 1893 901 19644348 10.1097/QAD. 0b013e32832dc041
24. KR Robertson Z Su DM Margolis, et al. 2010 Neurocognitive effects of treatment interruption in stable HIV-positive patients in an observational cohort Neurology 74 1260 6 20237308 10.1212/WNL.0b013e3181d9ed09 1:CAS:528:DC%2BC3cXkvV2qur8%3D
25. • Liner J, Robertson K, Meeker R. Antiretroviral neurotoxicity. Poster presented at 39th Annual Neuroscience Meeting. Chicago, IL; 2009. This study demonstrates the potential neurotoxic mechanisms of ART on neuronal cultures. This study demonstrates the possibility of neurotoxic side effects of antiretrovirals on neuronal cultures.
26. CM Marra Y Zhao DB Clifford, et al. 2009 Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance AIDS 23 1359 66 19424052 10.1097/QAD.0b013e32832c4152
27. A Calmy B Hirschel DA Cooper A Carr 2009 A new era of antiretroviral drug toxicity Antivir Ther 14 165 79 19430091 10.3851/IMP1418 1:CAS:528: DC%2BD1MXmtVOlsLg%3D
28. Ragin A, Wu Y, Du H, et al. Injury to the brain is evident early in HIV infection. 18th Conference on Retroviruses and Opportunistic; February 27-March 2, 2011; Boston MA. Abstract 55LB.
29. Valcour V, Sailasuta N, Chalermchai T, et al. HIV brain viral and inflammatory signature during acute infection. 18th Conference on Retroviruses and Opportunistic; February 27-March 2, 2011; Boston MA. Abstract 54.
30. EJ Wright 2009 Neurological disease: the effects of HIV and antiretroviral therapy and the implications for early antiretroviral therapy initiation Curr Opin HIV AIDS 4 447 52 20048710 10.1097/COH.0b013e32832dd0c2
31. MA Cole JB Margolick C Cox, et al. 2007 Longitudinally preserved psychomotor performance in long-term asymptomatic HIV-infected individuals Neurology 69 24 2213 20 17914066 10.1212/01.WNL.0000277520.94788.82 1:STN:280:DC%2BD2sjjt1Omsg%3D%3D (Pubitemid 350294676)
32. J Harezlak S Buchthal T Michael, et al. 2011 Persistence of HIV-associated cognitive impairment, inflammation, and neuronal injury in era of highly active antiretroviral treatment AIDS 25 5 625 33 21297425 10.1097/QAD.0b013e3283427da7 1:CAS:528:DC%2BC3MXislOksL8%3D
33. Smith G. Aging hearing: HIV over fifty, exploring the new threat. Senate Committee on Aging, 2006, Washington, DC.
34. Ledergerber B. Epidemiology of HIV, including Response to ART, in Older Populations. 15th Conference on Retroviruses and Opportunistic Infections. 2-12-2008; Abstract 108 [on-line]. Available at http://www.retroconference.org/ 2008/Abstracts/33417.htm Accessed April 6, 2009.
35. Collaboration of Observational HIV Epidemiological Research Europe (COHERE) Study Group 2008 Response to combination antiretroviral therapy: variation by age AIDS 22 1463 73 10.1097/QAD.0b013e3282f88d02
36. C Mussini C Manzardo M Johnson, et al. 2008 Patients presenting with AIDS in the HAART era: a collaborative cohort analysis AIDS 22 2461 9 19005269 10.1097/QAD.0b013e328314b5f1
37. NF Onen ET Overton W Seyfried, et al. 2010 Aging and HIV infection: a comparison between older HIV-infected persons and the general population HIV Clin Trials 11 2 100 9 20542846 10.1310/hct1102-100
38. SG Deeks 2011 HIV infection, inflammation, immunosenescence, and aging Annu Rev Med 62 141 55 21090961 10.1146/annurev-med-042909-093756 1:CAS:528:DC%2BC3MXivVWht7Y%3D
39. JS Currier JD Lundgren A Carr, et al. 2008 Epidemiological evidence for cardiovascular disease in HIV-infected patients and relationship to highly active antiretroviral therapy Circulation 118 e29 35 18566319 10.1161/CIRCULATIONAHA.107.189624 1:CAS:528:DC%2BD1cXoslClu7Y%3D
40. WM El-Sadr JD Lundgren JD Neaton, et al. 2006 CD4+ count-guided interruption of antiretroviral treatment N Engl J Med 355 22 2283 96 17135583 10.1056/NEJMoa062360 1:STN:280:DC%2BD28npvVSntw%3D%3D (Pubitemid 44837777)
41. K Samaras H Wand M Law, et al. 2007 Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia Diabetes Care 30 1 113 9 17192343 10.2337/dc06-1075 1:CAS:528:DC%2BD2sXhsFWqtbo%3D (Pubitemid 46052508)
42. TT Brown X Li SR Cole, et al. 2005 Cumulative exposure to nucleoside analogue reverse transcriptase inhibitors is associated with insulin resistance markers in the Multicenter AIDS Cohort Study AIDS 19 13 1375 83 16103768 10.1097/01.aids.0000181011.62385.91 1:CAS:528:DC%2BD2MXnvFymtrk%3D (Pubitemid 41800673)
43. SMART/INSIGHT and D:A:D Study Groups 2008 Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients AIDS 22 14 F17 24 10.1097/QAD.0b013e32830fe35e
44. EJ Wright B Grund K Robertson, et al. 2010 Cardiovascular risk factors associated with lower baseline cognitive performance in HIV-positive persons Neurology 75 10 864 73 20702792 10.1212/WNL.0b013e3181f11bd8 1:STN:280:DC%2BC3cfhvF2nsQ%3D%3D The SMART neurology substudy indicates an association between poorer neurocognitive performance and prior cardiovascular disease.
45. WM El Sadir JD Lundgren JD Neaton, et al. 2006 CD4+ count-guided interruption of antiretroviral treatment N Engl J Med 355 2283 96 10.1056/NEJMoa062360 (Pubitemid 44837777)
46. JT Becker L Kingsley J Mullen, et al. 2009 Vascular risk factors, HIV serostatus, and cognitive dysfunction in gay and bisexual men Neurology 73 1292 9 19841381 10.1212/WNL.0b013e3181bd10e7 1:STN:280:DC%2BD1MjgsVaqtQ%3D%3D
47. JT Becker OL Lopez MA Dew HJ Aizenstein 2004 Prevalence of cognitive disorders differs as a function of age in HIV virus infection AIDS 18 Suppl 1 S11 8 15075493
48. V Valcour C Shikuma B Shiramizu, et al. 2004 Higher frequency of dementia in older HIV-1 individuals: the Hawaii aging with HIV-1 cohort Neurology 63 5 822 7 15365130 1:STN:280:DC%2BD2cvls1yqug%3D%3D (Pubitemid 39297641)
49. L Malaspina S Woods D Moore C Depp SL Letendre D Jeste, et al. 2011 Successful cognitive aging in persons living with HIV infection J Neurovirol 17 110 9 21165783 10.1007/s13365-010-0008-z
50. DJ Hardy DE Vance 2009 The neuropsychology of HIV/AIDS in older adults Neuroppsychol Rev 19 263 72 10.1007/s11065-009-9087-0
51. WG van Gorp EN Miller TD Marcotte, et al. 1994 The relationship between age and cognitive impairment in HIV-1 infection: findings from the Muliticenter AIDS Cohort Study and a clinical cohort Neurology 44 929 35 8190299 (Pubitemid 24158812)
52. FL Wilkie K Goodkin I Khamis MH van Zuilen D Lee R Lecusy, et al. 2011 Cognitive functioning in younger and older HIV-1 infected adults J Acquir Immune Defic Syndr 33 93 105
53. MS Sulkowski DL Thomas 2003 Hepatitis C in the HIV-infected person Ann Intern Med 138 197 207 12558359 (Pubitemid 36231625)
54. G Greub B Ledergerber M Battegay, et al. 2000 Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study Lancet 356 1800 5 11117912 10.1016/S0140-6736(00)03232-3 1:STN:280:DC%2BD3M%2FmtlOltw%3D%3D
55. KB Anderson JL Guest D Rimland 2004 Hepatitis C virus coinfection increases mortality in HIV infected patients in the highly active antiretroviral therapy era: data from the HIV Atlanta VA Cohort Study Clin Infect Dis 39 1507 13 15546088 10.1086/425360 (Pubitemid 39518216)
56. MB Klein RG Lalonde S Suissa 2003 The impact of hepatitis C virus coinfection on HIV progression before and after highly active antiretroviral therapy J Acquir Immune Defic Syndr 33 365 72 12843748 10.1097/00126334- 200307010-00011 1:CAS:528:DC%2BD3sXnvFyjs7c%3D (Pubitemid 36859063)
57. J Stebbing L Waters S Mandalia, et al. 2005 Hepatitis C virus infection in HIV type 1-infected individuals does not accelerate a decrease in the CD4+ cell count but does increase the likelihood of AIDS-defining events Clin Infect Dis 41 906 11 16107994 10.1086/432885 1:CAS:528:DC%2BD2MXhtVKmurzP (Pubitemid 41266762)
58. CH Hinkin SA Castellon AJ Levine, et al. 2008 Neurocognition in individuals co-infected with HIV and hepatitis C J Addict Dis 27 11 7 18681187 10.1300/J069v27n02-02
59. WP Law CJ Duncombe A Mahanontharit, et al. 2004 Impact of viral hepatitis co-infection on response to antiretroviral therapy and HIV disease progression in the HIV-NAT cohort AIDS 18 1169 77 15166532 10.1097/00002030-200405210-00010 (Pubitemid 38738516)
60. JK Rockstroh 2006 Influence of viral hepatitis on HIV infection J Hepatol 44 S25 7 16338020 10.1016/j.jhep.2005.11.007 (Pubitemid 43053869)
61. PS Sullivan DL Hanson EH Teshale, et al. 2006 Effect of hepatitis C infection on progression of HIV disease and early response to initial antiretroviral therapy AIDS 20 1171 9 16691069 10.1097/01.aids.0000226958.87471. 48 (Pubitemid 43786106)
62. X Zhang J Xu H Peng, et al. 2008 HCV coinfection associated with slower disease progression in HIV-infected former plasma donors naive to ART PLoS One 3 e3992 19098990 10.1371/journal.pone.0003992
63. L Norman A Kumar 2006 Neuropsychological complications of HIV disease and substances of abuse Am J Infect Dis 2 115 24 10.3844/ajidsp.2006.115.124
64. J Davies IP Everall S Weich, et al. 1997 HIV-associated brain pathology in the United Kingdom: an epidemiological study AIDS 11 1145 50 9233462 10.1097/00002030-199709000-00010 1:STN:280:DyaK2sznslylsA%3D%3D (Pubitemid 27273612)
65. A Nath WF Maragos MJ Avison FA Schmitt JR Berger 2001 Acceleration of HIV dementia with methamphetamine and cocaine J Neurovirol 7 66 71 11519485 10.1080/135502801300069737 1:STN:280:DC%2BD3MvnsFKlug%3D%3D (Pubitemid 32904361)
66. MJ Ferris CF Mactutus RM Booze 2008 Neurotoxic profiles of HIV, psychostimulant drugs of abuse, and their concerted effect on the brain: current status of dopamine system vulnerability in NeuroAIDS Neurosci Biobehav Rev 32 883 909 18430470 10.1016/j.neubiorev.2008.01.004 1:CAS:528:DC%2BD1cXms1Whtr4%3D
67. TH Burdo SN Katner MA Taffe HS Fox 2006 Neuroimmunity, drugs of abuse, and neuroAIDS J Neuroimmune Pharmacol 1 41 9 18040790 10.1007/s11481-005-9001-3 (Pubitemid 44257499)
68. SL Simon CP Domier T Sim, et al. 2002 Cognitive performance of current methamphetamine and cocaine abusers J Addict Dis 21 1 61 74 11831501 10.1300/J069v21n01-06 (Pubitemid 35203854)
69. P Gaskill T Calderon A Luers, et al. 2009 Human immunodeficiency virus (HIV) infection of human macrophages is increased by dopamine: a bridge between HIV-associated neurologic disorders and drug abuse Am J Pathol 175 1148 59 19661443 10.2353/ajpath.2009.081067 1:CAS:528:DC%2BD1MXhtF2isb3F
70. JE Green RV Saveanu RA Bornstein 2004 The effect of previous alcohol abuse on cognitive function in HIV infection Am J Psychiatry 161 2 249 54 14754773 10.1176/appi.ajp.161.2.249 (Pubitemid 38419275)
71. MP Carrieri JP Moatti D Vlahov, et al. 1999 Access to antiretroviral treatment among French HIV infected injection users: the influence of continued drug use J Epidemiol Community Health 53 4 8 10326045 10.1136/jech.53.1.4 1:STN:280:DyaK1M3lslyqtw%3D%3D (Pubitemid 29012343)
72. DR Gibson J McCusker M Chesney 1998 Effectiveness of psychosocial interventions in preventing HIV risk behavior in injecting drug users AIDS 12 919 29 9631146 10.1097/00002030-199808000-00015 1:STN:280:DyaK1c3psVKjtQ%3D%3D (Pubitemid 28241406)
73. J McCusker J Westenhouse AM Stoddard, et al. 1990 Use of drugs and alcohol by homosexually active men in relation to sexual practices J Acquir Immune Defic Syndr 3 729 36 2352125 1:STN:280:DyaK3c3nvVOitQ%3D%3D (Pubitemid 20375247)
74. AJ Applebaum LC Reilly JS Gonzalez, et al. 2009 The impact of neuropsychological functioning on adherence to HAART in HIV-infected substance abuse patients AIDS Patient Care STDS 23 6 455 62 19519229 10.1089/apc.2008.0181
75. G Lucas 2010 Substance abuse, adherence with antiretroviral therapy, and clinical outcomes among HIV-infected individuals Life Sci 88 948 52 20888839 10.1016/j.lfs.2010.09.025